About UTI-lizer
UTI-lizer is a company based in Stockholm (Sweden) founded in 2021 by Emre Iseri, Wouter van der Wijngaart, and Sofia Bertling.. UTI-lizer has raised $284.74 thousand across 1 funding round from investors including Almi Invest. UTI-lizer offers products and services including Utilizer Test System. UTI-lizer operates in a competitive market with competitors including Microplate Dx, Diagnochip, ODx Innovations, PhenUtest and ARDIS, among others.
- Headquarter Stockholm, Sweden
- Founders Emre Iseri, Wouter van der Wijngaart, Sofia Bertling
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Utilizer Ab
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$284.74 K (USD)
in 1 rounds
-
Latest Funding Round
$284.74 K (USD), Seed
May 23, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of UTI-lizer
UTI-lizer offers a comprehensive portfolio of products and services, including Utilizer Test System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers accurate UTI testing results in near-patient settings to aid healthcare.
Funding Insights of UTI-lizer
UTI-lizer has successfully raised a total of $284.74K through 1 strategic funding round. The most recent funding activity was a Seed round of $284.74 thousand completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $284,737
-
First Round
First Round
(23 May 2023)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Seed - UTI-lizer | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in UTI-lizer
UTI-lizer has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Almi Invest. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by UTI-lizer
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - UTI-lizer
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Uti-Lizer Comparisons
Competitors of UTI-lizer
UTI-lizer operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Microplate Dx, Diagnochip, ODx Innovations, PhenUtest and ARDIS, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of a diagnostic test for drug-resistant infections
|
|
| domain | founded_year | HQ Location |
Designs and develops diagnostic devices for detecting urinary infections.
|
|
| domain | founded_year | HQ Location |
Provides rapid testing for antibiotic susceptibility in urinary tract infections and healthcare support.
|
|
| domain | founded_year | HQ Location |
Develops innovative diagnostic kits for urinary tract infections.
|
|
| domain | founded_year | HQ Location |
Develops innovative diagnostic technologies for pelvic floor disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about UTI-lizer
When was UTI-lizer founded?
UTI-lizer was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is UTI-lizer located?
UTI-lizer is headquartered in Stockholm, Sweden.
Who is the current CEO of UTI-lizer?
Sofia Bertling is the current CEO of UTI-lizer. They have also founded this company.
Is UTI-lizer a funded company?
UTI-lizer is a funded company, having raised a total of $284.74K across 1 funding round to date. The company's 1st funding round was a Seed of $284.74K, raised on May 23, 2023.
What does UTI-lizer do?
UTI-lizer was founded in 2021 in Stockholm, Sweden, within the health diagnostics sector. Point-of-care tests for urinary tract infections are developed, focusing on clinical relevance, speed, and cost-effectiveness. A digital dipstick has been created to detect infections with high sensitivity. Operations center on innovative diagnostic solutions for medical applications in the region.
Who are the top competitors of UTI-lizer?
UTI-lizer's top competitors include Microplate Dx, ARDIS and Diagnochip.
What products or services does UTI-lizer offer?
UTI-lizer offers Utilizer Test System.
Who are UTI-lizer's investors?
UTI-lizer has 1 investor. Key investors include Almi Invest.